Skip to content
Screener

Lexicon Pharmaceuticals LXRX Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Mannkind logo
MannkindMNKD
$11.76M-7.5%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$515K+214%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$1.5M-5.6%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$3.71M-41.8%
PTH
Pelthos TherapeuticsPTHS
$3.29M
LQD
Liquidia CorporationLQDA
$6.96M+1.5%

Other financials

Income statement

See full
Revenue$692.0K-97.6%
Gross profit$653.0K-97.7%
Operating income-$26.5M-810%
Net income-$31.8M-1,077%
EPS (diluted)-$0.07-800%

Balance sheet

See full
Cash & equivalents$40.9M-18.7%
Total debt$59.2M-3.6%
Total equity$174.5M+34.8%
Total assets$250.1M+10.9%

Cash flow

See full
Operating cash flow-$9.2M
CapEx--100%
Free cash flow-$17.2M+21.5%

Valuation

See full
Market cap$1.07B+183%
Enterprise value$1.09B+179%
P/S25.8×+19.3×

Profitability

See full
Gross margin99.1%0.0pp
Operating margin-131.4%-34.2pp
Net margin-147.4%-32.8pp
FCF margin-578.5%-283pp

Returns & leverage

See full
Return on equity-40.2%-11.2pp
Debt / equity0.3×-0.1×
Current ratio13.4×+9.2×

Where this comes from

Reported directly by Lexicon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001062822-26-000117
20291,753
20301,863
Thereafter2,979
Total undiscounted operating lease liability10,791
Less: amount of lease payments representing interest(2,987)
Present value of future lease payments7,804
Less: short-term operating lease liability(1,642)
Long-term operating lease liability$$6,162

Item 1. Financial Statements

FAQ

What is Lexicon Pharmaceuticals's operating lease liabilities (total)?
Lexicon Pharmaceuticals (LXRX) reported operating lease liabilities (total) of $7.8M in Q2 2026.
How has Lexicon Pharmaceuticals's operating lease liabilities (total) changed year-over-year?
Lexicon Pharmaceuticals's operating lease liabilities (total) increased by 46.0% year-over-year, from $5.34M to $7.8M.
What is the long-term trend for Lexicon Pharmaceuticals's operating lease liabilities (total)?
Over 2 years (2023 to 2025), Lexicon Pharmaceuticals's operating lease liabilities (total) has grown at a 12.1% compound annual growth rate (CAGR), from $6.56M to $8.23M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.

Ask your AI about Lexicon Pharmaceuticals's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude